Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.22.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock, at Cost
Total
Balance at Dec. 31, 2020 $ 50 $ 45,645 $ 210,952,473 $ (162,694,983)   $ 48,303,185
Balance (in shares) at Dec. 31, 2020 49,626 45,645,166        
Stock-Based Compensation Expense   $ 68 8,544,078     8,544,146
Stock-Based Compensation Expense (in shares)   68,047        
Stock Option Exercises   $ 568 673,191     673,759
Stock Option Exercises (in shares)   567,826        
Stock Warrant Exercises   $ 7,274 34,697,794     34,705,068
Stock Warrant Exercises (in shares)   7,274,328        
Proceeds from Common Stock Offerings   $ 4,768 97,784,270     97,789,038
Proceeds from Common Stock Offerings (in shares)   4,768,293        
Direct Costs of Common Stock Offerings     (6,136,420)     (6,136,420)
Shares Redeemed to Cover Employee Tax Withholdings   $ (83) (1,144,282)     (1,144,365)
Shares Redeemed to Cover Employee Tax Withholdings (in shares)   (83,164)        
Stock Issued for Technology License Purchase   $ 75 1,404,675     1,404,750
Stock Issued for Technology License Purchase (in shares)   75,000        
Preferred Stock Converted & Preferred Dividend Settlement $ (50) $ 4,963 (10,004,913)     (10,000,000)
Net Loss       (18,396,842)   (18,396,842)
Balance at Jun. 30, 2021   $ 63,278 336,770,866 (181,091,825)   155,742,319
Balance (in shares) at Jun. 30, 2021   63,278,096        
Balance at Mar. 31, 2021   $ 62,143 318,720,283 (171,846,353)   146,936,073
Balance (in shares) at Mar. 31, 2021   62,142,940        
Stock-Based Compensation Expense   $ 68 3,984,694     3,984,762
Stock-Based Compensation Expense (in shares)   68,047        
Stock Option Exercises   $ 337 476,593     476,930
Stock Option Exercises (in shares)   336,858        
Stock Warrant Exercises   $ 33 136,497     136,530
Stock Warrant Exercises (in shares)   33,300        
Proceeds from Common Stock Offerings   $ 622 12,748,752     12,749,374
Proceeds from Common Stock Offerings (in shares)   621,951        
Direct Costs of Common Stock Offerings     (700,628)     (700,628)
Stock Issued for Technology License Purchase   $ 75 1,404,675     1,404,750
Stock Issued for Technology License Purchase (in shares)   75,000        
Net Loss       (9,245,472)   (9,245,472)
Balance at Jun. 30, 2021   $ 63,278 336,770,866 (181,091,825)   155,742,319
Balance (in shares) at Jun. 30, 2021   63,278,096        
Preferred Stock Converted & Preferred Dividend Settlement (in shares) (49,626) 4,962,600        
Balance at Dec. 31, 2021   $ 63,672 346,736,397 (203,072,143)   143,727,926
Balance (in shares) at Dec. 31, 2021   63,672,268        
Stock-Based Compensation Expense   $ 289 8,538,153     8,538,441
Stock-Based Compensation Expense (in shares)   288,650        
Stock Option Exercises   $ 65 48,440     48,506
Stock Option Exercises (in shares)   64,722        
Purchases of Treasury Stock         $ (251,057) $ (251,057)
Purchases of Treasury Stock (in Shares)         (36,685) (36,685)
Net Loss       (20,527,668)   $ (20,527,668)
Balance at Jun. 30, 2022   $ 64,026 355,322,990 (223,599,811) $ (251,057) 131,536,148
Balance (in shares) at Jun. 30, 2022   64,025,640     36,685  
Balance at Mar. 31, 2022   $ 63,705 350,721,326 (213,578,143) $ (251,057) 136,955,831
Balance (in shares) at Mar. 31, 2022   63,704,626     (36,685)  
Stock-Based Compensation Expense   $ 289 4,582,414     4,582,703
Stock-Based Compensation Expense (in shares)   288,650        
Stock Option Exercises   $ 32 19,250     19,282
Stock Option Exercises (in shares)   32,364        
Net Loss       (10,021,668)   (10,021,668)
Balance at Jun. 30, 2022   $ 64,026 $ 355,322,990 $ (223,599,811) $ (251,057) $ 131,536,148
Balance (in shares) at Jun. 30, 2022   64,025,640     36,685